Revolution Medicines, Inc. (RVMDW)
Sector: Biological Products, (No Diagnostic Substances)
Revolution Medicines, Inc.
+0.43%$9.37
Mkt Cap$2.01B
Float193.04M
O/S214.34M
Inst Own-
SI<0.1%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$1.13B
Total Assets$2.35B
Free Cash Flow-$913.73M
Debt & Equity
Debt 9%
Equity 91%
Total Debt$158.7M
Total Equity$1.63B
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in RVMDW's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$2.35B
Liabilities$723.21M
Accounts Receivable$0
Accounts Payable$64.62M
Inventory$0
PP&E (Net)$165.28M
Goodwill$14.61M
Intangible Assets$55.8M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Revenue | $0 | $0 | $11.58M | $35.38M | $29.39M | $42.98M | $50.04M | $20.16M | $0 |
| YoY Growth | - | - | -67.3% | 20.4% | -31.6% | -14.1% | 148.2% | - | - |
| Cost of Revenue | $16.56M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $26.59M |
| Gross Profit | -$16.56M | $0 | $11.58M | $35.38M | $29.39M | $42.98M | $50.04M | $20.16M | -$26.59M |
| Gross Margin | - | - | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | - |
| Research and Development | $978.68M | $592.23M | $423.14M | $253.07M | $186.95M | $132.25M | $91.75M | $51.08M | $26.59M |
| Selling, General, and Administrative | $187.13M | $97.3M | $75.62M | $40.59M | $30.45M | $21.43M | $12.41M | $9.41M | $4.54M |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$26.59M |
| Total Operating Expenses | $1.17B | $689.52M | $498.76M | $293.66M | $217.4M | $153.68M | $104.16M | $60.49M | $4.54M |
| Operating Income (EBIT) | -$1.18B | -$689.52M | -$487.19M | -$258.28M | -$188.01M | -$110.7M | -$54.12M | -$40.33M | -$31.13M |
| Operating Margin | - | - | -4207.1% | -730.0% | -639.7% | -257.5% | -108.2% | -200.0% | - |
| Interest Expense | $24.23M | $0 | $303K | $0 | $12K | $71K | $106K | $116K | $103K |
| Interest Income | $90.69M | $86.88M | $47.48M | $9.15M | $929K | $2.24M | $2.19M | $777K | $105K |
| Other Income (Expense) | $51.07M | $88.68M | $47.29M | $9.15M | $917K | $2.17M | $2.08M | -$1.46M | $2K |
| Income Before Tax (EBT) | -$1.13B | -$600.85M | -$439.89M | -$249.13M | -$187.09M | -$108.53M | -$52.04M | -$41.79M | -$31.13M |
| Income Tax Expense | $0 | -$753K | -$3.52M | -$420K | $0 | -$371K | -$4.37M | $0 | $105K |
| Net Income | -$1.13B | -$600.09M | -$436.37M | -$248.71M | -$187.09M | -$108.16M | -$47.66M | -$41.79M | -$31.13M |
| Net Income Margin | - | - | -3768.3% | -703.0% | -636.6% | -251.6% | -95.2% | -207.2% | - |
| Supplementary Data | |||||||||
| EPS | -5.95 | -3.58 | -3.86 | -3.08 | -2.47 | -1.62 | -1.31 | -1.15 | -0.85 |
| Diluted EPS | -5.95 | -3.58 | -3.86 | -3.08 | -2.47 | -1.62 | -1.31 | -1.15 | -0.85 |
| Weighted Average OS | 190.13M | 167.74M | 113.15M | 80.63M | 72.81M | 66.60M | 36.47M | 36.47M | 36.47M |
| EBITDA | -$1.09B | -$589.02M | -$430.28M | -$239.47M | -$179.75M | -$101.91M | -$48.59M | -$39.91M | -$29.84M |
| EBITDA Margin | - | - | -3715.7% | -676.8% | -611.6% | -237.1% | -97.1% | -197.9% | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Assets | |||||||||
| Current Assets | |||||||||
| Cash and Cash Equivalents | $383.75M | $543.06M | $696.15M | $161.41M | $108.5M | $104.27M | $16.66M | $69.59M | $9.08M |
| Short-Term Investments | $1.64B | $1.75B | $1.16B | $483.53M | $468.56M | $336.47M | $106.1M | $0 | $0 |
| Cash and Short-Term Investments | $2.03B | $2.29B | $1.85B | $644.94M | $577.05M | $440.74M | $122.76M | $69.59M | $9.08M |
| Accounts Receivable | $0 | $0 | $1.25M | $4.67M | $5.93M | $6.39M | $8.74M | $7.3M | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $6.6M | $0 |
| Other Current Assets | $49.36M | $38.33M | $25.07M | $10.57M | $0 | $0 | $0 | $6.6M | $0 |
| Total Current Assets | $2.08B | $2.33B | $1.88B | $660.18M | $589.77M | $454.12M | $133.98M | $85.43M | $9.44M |
| Long-Term Assets | |||||||||
| Property, Plant & Equipment Net | $165.28M | $141.82M | $100.01M | $73.74M | $71.24M | $36.34M | $7.15M | $6.87M | $5.25M |
| Goodwill | $14.61M | $14.61M | $14.61M | $14.61M | $14.61M | $14.61M | $14.61M | $14.61M | $0 |
| Intangible Assets | $55.8M | $56.67M | $57.74M | $58.81M | $59.88M | $60.95M | $62.01M | $63.08M | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $43.78M | $17.57M | $10.06M | $4.59M | $2.5M | $1.39M | $2.78M | $593K | $383K |
| Total Long-Term Assets | $279.47M | $230.67M | $182.42M | $151.75M | $148.22M | $113.28M | $86.55M | $85.16M | $5.64M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $2.35B | $2.56B | $2.06B | $811.93M | $737.99M | $567.4M | $220.53M | $170.59M | $15.08M |
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts Payable | $64.62M | $54.43M | $61.79M | $21.31M | $14.06M | $12.61M | $11.4M | $5.24M | $3.35M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $4.46M | $12.36M | $12.11M | $17.12M | $16.83M | $0 |
| Other Current Liabilities | $66.05M | $31.36M | $27.51M | $13.79M | $10.16M | $7.83M | $5.73M | $6.06M | $2.55M |
| Total Current Liabilities | $290.42M | $163.91M | $143.85M | $61.98M | $60.35M | $47.18M | $43.05M | $30.55M | $7.6M |
| Long-Term Liabilities | |||||||||
| Long-Term Debt | $142.23M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $6.57M | $8.48M | $14.73M | $28.41M | $0 |
| Long-Term Deferred Tax Liabilities | $2.35M | $2.35M | $3.12M | $7.03M | $7.44M | $7.44M | $7.82M | $12.19M | $0 |
| Other Long-Term Liabilities | $288.2M | $3.86M | $7.97M | $301K | $634K | $632K | $2.4M | $2.77M | $2.95M |
| Total Long-Term Liabilities | $432.79M | $129.18M | $91.66M | $64.76M | $75.07M | $45.55M | $24.94M | $43.38M | $2.95M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $723.21M | $293.1M | $235.51M | $126.74M | $135.42M | $92.72M | $67.99M | $73.93M | $10.55M |
| Stockholders' Equity | |||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $305.11M | $205.08M | $72.25M |
| Common Stock | $19K | $18K | $16K | $9K | $8K | $7K | $0 | $0 | $0 |
| Retained Earnings | -$2.87B | -$1.74B | -$1.14B | -$701.34M | -$452.64M | -$265.55M | -$157.39M | -$109.72M | -$67.93M |
| Comprehensive Income & Other | $3.24M | $1.32M | $544K | -$1.78M | -$376K | $116K | $74K | $0 | $0 |
| Other Stockholders' Equity | $4.5B | $4B | $2.96B | $1.39B | $1.06B | $740.21M | $309.92M | $206.38M | $72.46M |
| Total Equity | $1.63B | $2.27B | $1.83B | $685.19M | $602.57M | $474.68M | $152.53M | $96.66M | $4.53M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $2.35B | $2.56B | $2.06B | $811.93M | $737.99M | $567.4M | $220.53M | $170.59M | $15.08M |
| Supplementary Data | |||||||||
| Total Debt | $158.7M | $135.84M | $87.94M | $64.2M | $66.63M | $32.66M | $0 | $147K | $0 |
| Net Debt | -$225.04M | -$407.22M | -$608.2M | -$97.21M | -$41.86M | -$71.6M | -$16.66M | -$69.44M | -$9.08M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Operating Activities | |||||||||
| Net Income | -$1.13B | -$600.09M | -$436.37M | -$248.71M | -$187.09M | -$108.16M | -$47.66M | -$41.79M | -$31.13M |
| Depreciation & Amortization | $16.56M | $11.82M | $9.31M | $9.66M | $7.33M | $6.54M | $3.34M | $1.76M | $1.19M |
| Deferred Income Tax | $0 | -$762K | -$3.91M | -$419K | $0 | -$375K | -$4.37M | $201K | $0 |
| Stock-Based Compensation | $118.39M | $79.2M | $61.77M | $31.2M | $20.72M | $8.89M | $3.16M | $855K | $141K |
| Changes in Working Capital: | |||||||||
| Accounts Receivable | $0 | $1.25M | $3.42M | $1.26M | $464K | $2.34M | -$1.43M | -$7.3M | $0 |
| Inventory | $0 | $0 | $0 | $0 | $7.68M | -$2.34M | $0 | $0 | $0 |
| Accounts Payable | $9.54M | -$6.46M | $32.47M | $7.29M | $2.24M | $305K | $5.26M | $109K | $1.97M |
| Other Working Capital | $77.29M | $6.38M | $4.77M | -$22.03M | -$1.66M | -$8.61M | -$8.29M | $37.95M | $2.68M |
| Total Working Capital Change | $86.82M | $1.17M | $40.66M | -$13.49M | $8.72M | -$8.3M | -$4.46M | $38.06M | $4.65M |
| Other Non-Cash Items | $11.79M | -$48.77M | -$22.04M | -$2.64M | $3.13M | $1.34M | $373K | $2.12M | $549K |
| Net Cash from Operating | -$897.74M | -$557.44M | -$350.57M | -$224.4M | -$147.18M | -$100.06M | -$49.62M | $1.21M | -$25.15M |
| Investing Activities | |||||||||
| Capital Expenditures | -$15.99M | -$10.31M | -$7.73M | -$10.82M | -$6.53M | -$2.93M | -$2.59M | -$1.5M | -$1.57M |
| Acquisitions | $0 | $0 | $0 | $13.3M | $135.59M | $231.3M | $6.2M | $160K | $0 |
| Purchases of Investments | -$1.79B | -$2.14B | -$1.06B | -$612.77M | -$671.34M | -$544.13M | -$172.27M | $0 | $0 |
| Sales of Investments | $1.93B | $1.59B | $724.05M | $599.47M | $535.75M | $312.83M | $66.69M | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | -$13.3M | -$135.59M | -$231.3M | $0 | $0 | $0 |
| Net Cash from Investing | $118.06M | -$554.39M | -$342.6M | -$24.12M | -$142.12M | -$234.23M | -$101.97M | -$1.34M | -$1.57M |
| Financing Activities | |||||||||
| Debt Repaid | -$244.22M | - | - | - | - | - | - | - | - |
| Common Stock Issuance | $377.09M | $959.13M | $392.39M | $298.05M | $291.24M | $420.07M | $98.7M | $420K | $74K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | -$45K | -$131K | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $220K | $284K | $836.81M | $3.39M | $2.94M | $2.71M | $0 | $289K | $22.66M |
| Net Cash from Financing | $621.52M | $959.41M | $1.23B | $301.43M | $294.18M | $422.78M | $98.66M | $60.85M | $22.66M |
| Forex Effect | $0 | -$667K | -$1.29M | $0 | $0 | $0 | -$1 | $0 | $0 |
| Net Change in Cash | -$158.16M | -$153.08M | $534.74M | $52.91M | $4.88M | $88.48M | -$52.93M | $60.72M | -$4.06M |
| Supplementary Data | |||||||||
| Operating Cash Flow | -$897.74M | -$557.44M | -$350.57M | -$224.4M | -$147.18M | -$100.06M | -$49.62M | $1.21M | -$25.15M |
| Capital Expenditure | -$15.99M | -$10.31M | -$7.73M | -$10.82M | -$6.53M | -$2.93M | -$2.59M | -$1.5M | -$1.57M |
| Free Cash Flow | -$913.73M | -$567.74M | -$358.3M | -$235.22M | -$153.71M | -$103M | -$52.2M | -$286K | -$26.72M |
| Cash at Beginning | $546.76M | $696.15M | $161.41M | $110.23M | $105.35M | $16.87M | $69.59M | $9.08M | $13.14M |
| Cash at End | $388.6M | $543.06M | $696.15M | $163.15M | $110.23M | $105.35M | $16.66M | $69.8M | $9.08M |